Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter
Active & ResponsiveNew

Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans

for
Healthy Adult Participants, Age 65 and Older, Age 18 to 40,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07914673

Phase 4, Recruiting
Active & Responsive

Autologous Dendritic Cell Vaccine in Kidney Cancer

for
Carcinoma, Renal Cell
Location: Pittsburgh PA
Sponsor: Jodi Maranchie

Sex: All

Age: 18+

Code: NCT05127824

Phase 2, Recruiting
Active & Responsive

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT04248569

Phase 1, Recruiting
Active & Responsive

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Boston MA, Atlanta GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06059391

Phase 2, Recruiting
Active & Responsive

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 12+

Code: NCT07430202

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

for
Human Papilloma Virus, Anal Dysplasia, HIV
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18 - 70

Code: NCT06624839

Phase 2, Recruiting
Active & Responsive

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

for
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,
Location: Boston MA, Atlanta GA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07020533

Phase 1, Recruiting
Active & Responsive

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07078604

Phase 2, Recruiting
Active & Responsive

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

for
Prostate Cancer Patients, Non-castrate Prostate Cancer,
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT07090148

Phase 1, Recruiting
Active & Responsive

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

for
Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT07495124

Phase 2, Recruiting
Active & Responsive

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

for
Liver Transplant
Location: Philadelphia PA, Baltimore MD, Durham NC, Miami FL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT06075745

Phase 2, Recruiting
Active & Responsive

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

for
Shigella, Diarrhea
Location: Cincinnati OH
Sponsor: Inventprise Inc.

Sex: All

Age: 18 - 49

Code: NCT07205926

Phase 1, Recruiting
Active & Responsive

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

for
Squamous Cell Carcinoma of Head and Neck
Location: Mineola NY, New York NY, Little Rock AR,
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT05952934

Phase 2, Recruiting
Active & Responsive

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

for
Human Papillomavirus Type 16,
Location: Baltimore MD, Birmingham AL
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 19+

Code: NCT04131413

Phase 1, Recruiting
Active & Responsive

Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination

for
Yellow Fever, Immunization; Infection
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 20 - 49

Code: NCT05859490

Phase 1, Phase 2, Recruiting
Active & Responsive

Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults

for
COVID-19
Location: Portsmouth VA, Miami FL, Miami Lakes FL, McKinney TX,
Sponsor: Ocugen

Sex: All

Age: 18+

Code: NCT05258669

Phase 2, Phase 3, Recruiting
Active & Responsive

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

for
Alzheimer Disease, Alzheimer Disease (AD),
Location: Miami Lakes FL
Sponsor: Nuravax, Inc.

Sex: All

Age: 40 - 65

Code: NCT07142278

Phase 1, Recruiting
Active & Responsive

Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations

for
No Disease or Condition is Being Directly Studied,
Location: Erie PA
Sponsor: Lake Erie College of Osteopathic Medicine

Sex: All

Age: 18+

Code: NCT07786467

Recruiting
Active & Responsive

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

for
Borderline Resectable/Unresectable Pancreatic Cancer,
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT07539155

Phase 1, Phase 2, Recruiting
Active & Responsive

MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults

for
Neisseria Meningitidis
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18 - 25

Code: NCT07197762

Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial